跳至主要内容
临床试验/EUCTR2006-004373-10-NL
EUCTR2006-004373-10-NL进行中(未招募)不适用

The effect of short term Topiramate treatment on insulin secretion, glucose- and lipid metabolism in obese women - Effect of Topiramate on glucose and lipid metabolism in obese women

Top institute of Pharmaceutical Research0 个研究点开始时间: 2008年2月28日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • -Female volunteers
  • -Age > 18 years and < 70 years
  • -BMI > 27 kg/m2 and < 44 kg/m2
  • -Fasting serum glucose (FSG) > 6.1 and < 7.0 mmol/L
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -FSG >6 mmol/L
  • -Psychiatric disorders and/or use of antipsychotic or antidepressants drugs at present or in the past.
  • -Any significant chronic disease
  • -Any significant abnormal laboratory results found during the medical screening procedure
  • -Renal, hepatic or endocrine disease (including DM)
  • -Use of medication known to influence lipolysis and/or glucose metabolism
  • -Premenopausale women who do not use oral contraceptives or intrauterine device
  • -Recent weight changes of attempts to loose weight (> 3 kg weight gain or loss, within the last 3 months)
  • -Difficulties to insert an intravenous catheter
  • -Severe claustrophobia (ventilated hood)
  • -Recent blood donation (within the last 3 months)
  • -Recent participation in other research projects (within the last 3 months), participation in 2 or more projects in one year

研究者

发起方
Top institute of Pharmaceutical Research

相似试验